Exact Sciences Corporation EXAS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score

36/100

1/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Exact Sciences Corporation (EXAS), dont 19 achats et 29 ventes. Le total des achats d'initiés s'élève à $13.89K et le total des ventes d'initiés à $4.47M.

Les initiés notables ayant une activité récente comprennent Coward D Scott, Orville Jacob A, Trigg Leslie. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — EXAS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-23	Coward D Scott	Director	Restitution d'Actions	12,875	$98.18	$1.26M	-
2026-03-23	Orville Jacob A	EVP, GM, Screening	Restitution d'Actions	38,707	-	-	-
2026-03-23	Trigg Leslie	Director	Restitution d'Actions	13,925	-	-	-
2026-03-23	Conroy Kevin T	President and CEO	Restitution d'Actions	154,829	-	-	-
2026-03-23	Popovits Kimberly J	Director	Restitution d'Actions	9,656	-	-	-
2026-03-23	Zanotti Katherine S	Director	Restitution d'Actions	5,398	-	-	-
2026-03-23	Clancy Paul J	Director	Restitution d'Actions	5,398	-	-	-
2026-03-23	Doyle James Edward	Director	Restitution d'Actions	5,398	-	-	-
2026-03-23	Petrovic Shacey	Director	Restitution d'Actions	7,095	$0.01	$70.95	-
2026-03-23	Condella Sarah	EVP, Human Resources	Restitution d'Actions	23,224	-	-	-
2026-03-23	Barber Michael J	Director	Restitution d'Actions	7,422	-	-	-
2026-03-23	Baranick Brian	EVP, GM, Precision Oncology	Restitution d'Actions	28,063	-	-	-
2026-03-23	Herriott James	SVP, General Counsel & Sec	Restitution d'Actions	20,321	-	-	-
2026-03-23	Bloomer Aaron	EVP, Chief Financial Officer	Restitution d'Actions	28,063	-	-	-
2026-02-27	Conroy Kevin T	President and CEO	Exercice d'Options (Vente)	18,143	-	-	18,143
2026-02-27	Condella Sarah	EVP, Human Resources	Exercice d'Options (Vente)	3,900	$5.03	$19.62K	-
2026-02-25	Orville Jacob A	EVP, GM, Screening	Attribution de RSU	38,707	-	-	38,707
2026-02-25	Conroy Kevin T	President and CEO	Attribution de RSU	154,829	-	-	154,829
2026-02-25	Condella Sarah	EVP, Human Resources	Attribution de RSU	23,224	-	-	23,224
2026-02-25	Baranick Brian	EVP, GM, Precision Oncology	Attribution de RSU	28,063	-	-	28,063
2026-02-25	Herriott James	SVP, General Counsel & Sec	Attribution de RSU	20,321	-	-	20,321
2026-02-25	Bloomer Aaron	EVP, Chief Financial Officer	Attribution de RSU	28,063	-	-	28,063
2025-12-24	Baranick Brian	EVP, GM, Precision Oncology	Retenue Fiscale RSU	14,938	$101.59	$1.52M	103,874
2025-12-23	Orville Jacob A	EVP, GM, Screening	Exercice d'Options (Vente)	16,051	-	-	-
2025-12-23	Baranick Brian	EVP, GM, Precision Oncology	Exercice d'Options	9,450	-	-	33,764
2025-06-13	Zanotti Katherine S	Director	Vente Informative	3,207	$53.20	$170.61K	72,759
2025-06-12	Levangie Daniel J	Director	Attribution de RSU	5,398	-	-	34,312
2025-06-12	Coward D Scott	Director	Attribution de RSU	5,398	-	-	57,562
2025-06-12	Trigg Leslie	Director	Attribution de RSU	7,670	-	-	17,169
2025-06-12	Popovits Kimberly J	Director	Attribution de RSU	9,994	-	-	16,381
2025-06-12	Zanotti Katherine S	Director	Attribution de RSU	5,398	-	-	75,966
2025-06-12	Clancy Paul J	Director	Attribution de RSU	5,398	-	-	26,038
2025-06-12	Doyle James Edward	Director	Attribution de RSU	5,398	-	-	61,447
2025-06-12	Petrovic Shacey	Director	Attribution de RSU	5,398	-	-	21,804
2025-06-12	Barber Michael J	Director	Attribution de RSU	7,197	-	-	13,136
2025-05-06	Herriott James	SVP, General Counsel & Sec	Attribution de RSU	7,334	-	-	7,334
2025-04-30	Herriott James	SVP, General Counsel & Sec	Attribution de RSU	363	$38.26	$13.89K	15,585
2025-04-29	Trigg Leslie	Director	Inconnu	-	-	-	972
2025-04-29	Trigg Leslie	Director	Attribution de RSU	8,527	-	-	9,499
2025-04-15	Bloomer Aaron	EVP, Chief Financial Officer	Exercice d'Options (Vente)	11,566	-	-	-
2025-03-07	Conroy Kevin T	President and CEO	Exercice d'Options (Vente)	66,723	$22.38	$1.49M	-
2025-03-03	Condella Sarah	EVP, Human Resources	Don (Donné)	1,055	-	-	81,483
2025-02-28	Orville Jacob A	EVP, GM, Screening	Exercice d'Options (Vente)	4,725	-	-	9,450
2025-02-28	Conroy Kevin T	President and CEO	Exercice d'Options (Vente)	18,143	-	-	36,286
2025-02-28	Condella Sarah	EVP, Human Resources	Exercice d'Options (Vente)	3,780	-	-	7,560
2025-02-28	Baranick Brian	EVP, GM, Precision Oncology	Exercice d'Options (Vente)	4,725	-	-	9,450
2025-02-28	Herriott James	SVP, General Counsel & Sec	Exercice d'Options (Vente)	1,890	-	-	3,780
2025-02-25	Orville Jacob A	EVP, GM, Screening	Exercice d'Options (Vente)	3,954	-	-	3,955
2025-02-25	Conroy Kevin T	President and CEO	Exercice d'Options (Vente)	13,180	-	-	13,181
2025-02-25	Condella Sarah	EVP, Human Resources	Exercice d'Options (Vente)	3,954	-	-	3,955

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration